Ilkow et al. demonstrated that VSV-based therapeutics were enhanced via crosstalk between CAFs and cancer cells.103 In contrast, transforming growth factor-beta 1 (TGF-β1) secreted by tumor cells was involved in promoting OV infection of CAFs. The gene discussed is TGFB1; the disease is infection.